Core Points - Dazhonglin's stock price increased by 2.07% on October 21, reaching 18.77 CNY per share, with a total market capitalization of 21.376 billion CNY [1] - The company has seen a year-to-date stock price increase of 27.25%, with a 5-day increase of 11.66% and a 20-day increase of 8.56% [1] - Dazhonglin's main business includes retail of traditional Chinese and Western medicine, health products, and medical devices, with 76.88% of revenue coming from Western and Chinese medicine [1] Financial Performance - For the first half of 2025, Dazhonglin reported revenue of 13.523 billion CNY, a year-on-year increase of 1.33%, and a net profit of 798 million CNY, up 21.38% [2] - The company has distributed a total of 3.355 billion CNY in dividends since its A-share listing, with 1.624 billion CNY distributed in the last three years [3] Shareholder Information - As of June 30, 2025, Dazhonglin had 31,500 shareholders, a decrease of 10.07% from the previous period, with an average of 36,097 circulating shares per shareholder, an increase of 11.20% [2] - Hong Kong Central Clearing Limited is the fourth largest circulating shareholder, holding 90.448 million shares, an increase of 12.4318 million shares from the previous period [3]
大参林涨2.07%,成交额3831.61万元,主力资金净流出53.54万元